Search results
If you are looking for research summaries please go to the research summary page.
920 results for at
- World Cancer Day: a blog by patient advocate Richard Stephens
- Helping to shape complex and innovative research regulation – a blog by Stephanie Ellis, Hampstead Research Ethics Committee Chair
- HRA User Satisfaction Report - October 2024 to March 2025
- Board Declaration of Interest Register
- Radiation Assurance: one year on
- The NHS R&D Forum 2019: HRA highlights from the conference
- What is Dynamic Consent? A blog by Dr Harriet TeareWhat is Dynamic Consent?
- I’m developing medical software
- HRA pharmacy reviewer role description
- Applying for Pharmacy Assurance
- Poor research transparency: excuses or genuine barriers? A blog by Juliet Tizzard, Director of Policy
- Privacy notice
- GDPR transparency wording for all sponsors
- The view from the Confidentiality Advisory Group: outgoing chair blogsAfter five years as chair (and several more as a member before that), Dr Mark Taylor is stepping down from the Confidentiality Advisory Group. As Dr Taylor leaves to take on a new role at Melbourne Law School in Australia, he describes how the group gave him a fresh insight into discussions of how the privacy of patients sits alongside the public interest.
- Reviewing how the NHS supports educational research: consultation
- HRA Approval – one year onHealth and social care researchers used to be faced with a very complex regulatory system – everyone agreed we needed a new approach. So we consulted with a wide range of stakeholders to develop HRA Approval, which brings together the assessment of legal compliance and the ethics review into one streamlined system.
- HRA Approval cohort 4 confirmedImplementation of HRA Approval continues, with the third cohort of studies incorporating all study types which exclude the first four categories of IRAS from 30 November 2015. This extends HRA Approval to a broad range of studies other than clinical trials or clinical investigations taking place in secondary care in the NHS. Early studies for this cohort have included cross-border studies with the devolved administrations, managed through compatible arrangements between the nations.
- Apply to RECsThis section focuses on the steps you need to follow in order to apply to a Research Ethics Committee.
- Making the UK a great place to do clinical trials – our response to the ABPI report
- Help us test a new draft Commercial Site Selected Letter of Intent